SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Koerwer Dan

(Last)

(First)

(Middle)

C/O BIND THERAPEUTICS, INC.

325 VASSAR STREET

(Street)

CAMBRIDGE

02139

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/19/2013

3. Issuer Name and Ticker or Trading Symbol
BIND Therapeutics, Inc [ BIND ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, BD and Commerical

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	7,633	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	⁽¹⁾	10/06/2020	Common Stock	65,988⁽¹⁾	$1.63	D
Employee Stock Option (right to buy)	⁽²⁾	10/06/2020	Common Stock	6,997⁽²⁾	$1.63	D
Employee Stock Option (right to buy)	⁽³⁾	04/23/2022	Common Stock	11,450⁽³⁾	$2.52	D
Employee Stock Option (right to buy)	⁽⁴⁾	04/23/2022	Common Stock	8,015⁽⁴⁾	$2.52	D
Employee Stock Option (right to buy)	⁽⁵⁾	04/22/2023	Common Stock	4,965⁽⁵⁾	$2.78	D

Explanation of Responses:

1. On October 7, 2010, the reporting person was granted an option to purchase 73,622 shares of common stock. Beginning on August 23, 2010, the option vests 25% after one year and in 36 equal monthly installments thereafter. On August 15, 2013, the reporting person exercised the option with respect to 7,633 shares.

2. On October 7, 2010, the reporting person was granted an option to purchase 27,608 shares of common stock. The option is immediately exercisable and vests upon the achievement of certain business development milestones. Certain of the milestones criteria have been met, resulting in vesting of the option as to 6,997 shares.

3. Beginning on March 1, 2012, the option vests 25% after one year and in 36 equal monthly installments thereafter.

4. On April 24, 2012, the reporting person was granted an option to purchase 11,450 shares of common stock. The option vests upon the achievement of certain business development milestones. Certain of the milestones criteria have been met, resulting in vesting of the option as to 8,015 shares.

5. Beginning on April 1, 2013, the option vests 25% after one year and in 36 equal monthly installments thereafter.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Andrew Hirsch, attorney-in-fact	09/19/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.